FiercePharma: Amgen, Teva hikes show pharma can’t blame rebates for all price increases: analyst

FiercePharma: Amgen, Teva hikes show pharma can’t blame rebates for all price increases: analyst

One analyst is pointing to two increases—both involving cancer drugs—as evidence that drugmakers sometimes raise prices simply “because they can.”